Clinical experience with some 50 uremic children and infants suggests a definite role for CAPO (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) , but its wider adoption requires an answer to the question whether adequate growth can be obtained with this modality of treatment. On the basis of careful measurements in 36 children, some preliminary observations can now be made on this important issue.
Children were observed to grow at a rate of 0.26 cm per month in Birmingham (1), 0.31 cm per month in Toronto (2), 0.36 cm per month in Naples (7) , and 0.29 cm per month in San Francisco (8) . In Zurich one child did not grow at all, while in another growth averaged 0.20 cm per month -even though both received 1:25-dihydrocholecalciferol supplements (9) . In a study of nine children carried out for one year, the standard deviation score for both sexes averaged -0.44; -two of these children did not grow and in only one was there a positive Standard Deviation Score (catch-up growth) (10) .
In our studies of five children undergoing CAPO for 58 months, the Standard Deviation Score was nearly normal in one boy, and one girl reached her final height during treatment (her growth at the beginning of CAPO was normal). In one bady treated by CAPO for more than one year, growth was normal (12) . Overall, these results do not arouse enthusiasm, especially since growth rates are no better than with hemodialysis (13) . Yet it must be emphasized that most of the children on CAPO were 12 years or older, so that their growth potential was reduced (14, 15) .
From the experience of the Seattle group, which used intermittent peritoneal dialysis in some 29 children (540 patient-months) (16) it may be inferred that children with growth potential did grow (growth curves below the 10th centile or below), and that many of them reached the third centile before growth ceased. Two uremic babies treated by intermittent peritoneal dialysis for one year showed poor growth (17) even though their energy and protein intakes were over the 67% of the RDA which is the minimum requirement for normal growth in children undergoing hemodialysis.
With CAPO it has to be pointed out that a number of factors related to growth retardation in uremic children are favou rably affected: these include energy malnutri-The International Journal Of Artificial Organs / Vol. 5 no. 6.1982/ p.p. 331-332 © by Wichtig Editore sri, 1982 tion, protein malnutrition, calcium and phosphate levels, hyperparathyroidism, levels of retained toxic products, acidosis, anemia, and hypertension.
In our experience, by taking into account the energy derived from the dialysate glucose and from the diet, we were able to provide an energy input averaging 100% of RDA and a protein intake of 135% of the RDA (7, 11) . During treatment glucose intolerance was somewhat ameliorated, as shown by intravenous glucose tolerance tests with normal values for Early and Late Insulin Responses, as well as the K disappearance rate for glucose (11) . In addition, nitrogen balance was positive in short and long term studies (7, 11) , a finding in keeping with data from our laboratory in adult patients undergoing CAPO (18) or short daily peritoneal dialyses (19) .
The levels of small and middle molecules are very low with CAPO; and low urea levels may be important for reducing urea generation rates (20) and maintaining positive nitrogen balance. Control of phosphate levels may usually may be achieved without phosphate bindes, the mean reported level being 4.65 mg/dl (11) . Calcium balance may be positive during CAPO (21) . Some of the parathormone fractions are also removed during the therapy, and in addition on tends to find normal bicarbonate levels (22) , acceptable packed cell volumes, and the absence of hypertension.
-All these data cast some doubts on the validity of our present understanding of what factors (23) are responsible for growth retardation to end stage renal disease in children. More studies are required before we can establish the new rationale for research in this field. foot ulcers, edema -the list is long and daunting. No wonder that some humane physicians have regarded the onset of uremia in the diabetic as a welcome release, the equivalent of pneumonia (<<the old man's frlend») in the elderly. The early poor results with hemodialysis (1) seemed to support this view, but with time a more positive attitude has emerged. Most diabetic patients, though afflicted with many complications, expect to be treated and do not agree that they are ready to die. Most dialysis units, furthermore, are well suited to treat these patients, being skilled in the management of both chronic illnesses
